Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H22FN3O |
| Molecular Weight | 375.4387 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FCCCCCN1C=C(C(=O)NC2=C3C=CC=CC3=CC=C2)C4=C1C=CN=C4
InChI
InChIKey=BRRZRRZUERBDQL-UHFFFAOYSA-N
InChI=1S/C23H22FN3O/c24-12-4-1-5-14-27-16-20(19-15-25-13-11-22(19)27)23(28)26-21-10-6-8-17-7-2-3-9-18(17)21/h2-3,6-11,13,15-16H,1,4-5,12,14H2,(H,26,28)
| Molecular Formula | C23H22FN3O |
| Molecular Weight | 375.4387 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:21:52 GMT 2025
by
admin
on
Mon Mar 31 23:21:52 GMT 2025
|
| Record UNII |
Q7GH2GGJ3E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-5F-PCN
Created by
admin on Mon Mar 31 23:21:52 GMT 2025 , Edited by admin on Mon Mar 31 23:21:52 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
125181244
Created by
admin on Mon Mar 31 23:21:52 GMT 2025 , Edited by admin on Mon Mar 31 23:21:52 GMT 2025
|
PRIMARY | |||
|
DTXSID901032641
Created by
admin on Mon Mar 31 23:21:52 GMT 2025 , Edited by admin on Mon Mar 31 23:21:52 GMT 2025
|
PRIMARY | |||
|
2219332-48-4
Created by
admin on Mon Mar 31 23:21:52 GMT 2025 , Edited by admin on Mon Mar 31 23:21:52 GMT 2025
|
PRIMARY | |||
|
Q7GH2GGJ3E
Created by
admin on Mon Mar 31 23:21:52 GMT 2025 , Edited by admin on Mon Mar 31 23:21:52 GMT 2025
|
PRIMARY | |||
|
5F-PCN
Created by
admin on Mon Mar 31 23:21:52 GMT 2025 , Edited by admin on Mon Mar 31 23:21:52 GMT 2025
|
PRIMARY | CAS: 325373-36-9 given is a non valid CAS Registry Number. | ||
|
5F-PCN
Created by
admin on Mon Mar 31 23:21:52 GMT 2025 , Edited by admin on Mon Mar 31 23:21:52 GMT 2025
|
PRIMARY | 5F-PCN (also known as 5-F-MN-21) is an azaindole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is closely related to NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-PCN may release 1-naphthylamine, a known carcinogen. Sweden's public health agency suggested to classify 5F-PCN as hazardous substance on November 10, 2014. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
